← All claims

Supplements · Diets · Metabolic & Cardiometabolic

garlic decreases fasting blood glucose

In plain terms: Does garlic lower blood sugar?

Strong support Supplements 🔎 Limited evidence — fewer than 12 studies

Part of: 🧪 Garlic

RefutedContestedStrong support
consensus score 0.90

Probably a little, in people with type 2 diabetes — studies consistently point the same way (fasting glucose down ~7–12 mg/dL). But the trials are small, low-quality, and wildly inconsistent in size, so treat it as a modest, uncertain add-on, not a real glucose treatment.

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

7 support 0 contradict 0 tested null 1 mixed · 8 sources, 7 independent groups

What the evidence shows

Across multiple meta-analyses of type-2-diabetes trials, garlic consistently lowers fasting blood glucose (~7–12 mg/dL) and HbA1c. **Direction is consistent but certainty is low** — the trials are small, mostly low-quality, and extremely heterogeneous (I² up to 99%), so the true magnitude is uncertain.

The evidence (8)

SourceGradeStanceQualityFinding
Ebrahimzadeh A et al.
2026 · Nutr Metab Insights
meta-analysis supports low Meta 8 RCTs in T2D: FBS -12.4 mg/dL, HbA1c -0.5%; authors flag low study quality and extreme heterogeneity (I2 96-99%).
Kumar R et al.
2013 · Diabetes Metab Syndr Obes
RCT mixed moderate Open-label n=60: metformin+garlic vs metformin - greater FBG/PPG reduction but HbA1c change NOT significant.
Sobenin IA et al.
2007 · Acta Diabetol
RCT supports moderate RCT n=60: time-released garlic lowered fasting glucose + fructosamine + triglycerides vs placebo over 4 wk.
Zhao X et al.
2024 · Nutrients
meta-analysis supports moderate Meta: fasting glucose -7.0 mg/dL, HbA1c -0.66% in mixed adults (moderate HbA1c heterogeneity).
Hou LQ et al.
2015 · Asia Pac J Clin Nutr
meta-analysis supports moderate Meta 7 RCTs (513, mixed diabetic/non-diabetic): fasting glucose lowered (SMD -1.67); too few studies to pool HbA1c reliably.
Wang J et al.
2017 · Food Nutr Res
meta-analysis supports moderate Meta 9 RCTs (768 T2D, allicin-standardized): dose/time-dependent fasting-glucose reduction plus lower fructosamine and HbA1c.
Ashraf R et al.
2011 · Pak J Pharm Sci
RCT supports low Small single-center RCT (n=60 T2D on metformin): modest extra fasting-glucose reduction vs placebo over 24 wk.
Behrouz V et al.
2026 · Nutr Rev
meta-analysis supports high Meta 108 RCTs (n=7137): FBG -2.77 mg/dL, insulin -1.74, HOMA-IR -0.37; stronger in unfavorable-baseline; more high-quality RCTs needed.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.